TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma

SIMPLE SUMMARY: Most patients with glioblastoma (GBM) develop recurrent diseases which can be treated with different approaches. Given the aggressive and resilient nature of GBM, continued efforts to better understand GBM pathophysiology are required to discover novel targets for future therapy. The...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Campolo, Michela, Lanza, Marika, Casili, Giovanna, Paterniti, Irene, Filippone, Alessia, Caffo, Maria, Cardali, Salvatore M., Puliafito, Ivana, Colarossi, Cristina, Raciti, Gabriele, Cuzzocrea, Salvatore, Esposito, Emanuela
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7794959/
https://ncbi.nlm.nih.gov/pubmed/33375627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010041
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados